KalVista Pharmaceuticals, Inc. Common Stock logo

KalVista Pharmaceuticals, Inc. Common Stock (KALV) Technical Analysis

$26.790.07%

Market is closed - opens 7 PM, 26 May 2026

Insights

  • KalVista Pharmaceuticals Common Stock is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for KalVista Pharmaceuticals Common Stock stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, KalVista Pharmaceuticals Common Stock stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for KalVista Pharmaceuticals Common Stock stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
74.55
Sell
Stochastic
63.64, 69.7
Neutral
Ultimate Oscillator
57.9
Neutral
Stochastic Relative Strength Index
22.52, 31.71
Neutral
Moving Average Convergence Divergence
1.65, 1.84
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
26.76
Buy
20
25.62
Buy
50
21.49
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
26.52
Buy
20
25.4
Buy
50
22.46
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
26.76
Neutral
20
26.58
Neutral
50
25.09
Buy

Double Exponential Moving Average

Period (Days)

Value

Action

10
27.27
Sell
20
27.71
Buy
50
26.03
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
26.81
Sell
20
27.79
Buy
50
27.73
Buy

Pivot

Pivot

Value

Resistance L3
26.91
Resistance L2
26.87
Resistance L1
26.84
Pivot Point
26.8
Support L1
26.77
Support L2
26.73
Support L3
26.7

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.